Clinical Trials Logo

Diabetes Mellitus, Type 2 clinical trials

View clinical trials related to Diabetes Mellitus, Type 2.

Filter by:

NCT ID: NCT05430139 Recruiting - Diabetes Clinical Trials

Dried Blood Spot Testing for At Home Health

Start date: October 31, 2022
Phase:
Study type: Observational

DBS (Dried blood spot) is the collection of a small volume of blood on paper cards and subsequent transport to an analytical laboratory. This method is widely used for newborn screening programs around the world to identify inborn errors of metabolism where early diagnosis and treatment can be lifesaving. The World Health Organization and World Anti-Doping Agency (WADA) have independently endorsed DBS as an alternative to conventional testing methods due to its lessened invasiveness, lower collection and transport cost, reduction in sample storage needs, and for some analytes, improved sample stability. There are hundreds of publications describing DBS testing and some commercial ventures offering direct-to-consumer testing using DBS. However, it is not clear if there have been concerted efforts to develop DBS sampling for adults for home collection in concert with high quality, accredited central clinical laboratories. The proposal herein is focused on developing and validating DBS for at home and remote sample collections for routine diagnostic testing.

NCT ID: NCT05430061 Completed - Obesity Clinical Trials

Crossover Trials Which Assessed Consumption of Slowly Digestible Carbohydrates for 21 Days on Gastric Emptying Rates

INT
Start date: July 27, 2017
Phase: N/A
Study type: Interventional

To gain a better understanding about the conditioning effect of consumption of slowly digestible carbohydrate on gastric emptying rate, respiratory quotient and metabolic flexibility, this study will focus on monitoring change in gastric emptying with consumption of a single source of slowly digestible carbohydrate (30 g of raw corn starch) for 21 days and compared to a control (21 days of continious consumption of rapidly digesting carbohydrate maltodextrin).

NCT ID: NCT05429359 Not yet recruiting - Clinical trials for Diabetes Mellitus, Type 1

cArdiopulmonary exerCise Test Assessing Multiple biOmarkers and Hormones iN Type 1 diabetEs Under Different Circumstances

ACT-ONE
Start date: October 1, 2022
Phase: N/A
Study type: Interventional

Collection of venous blood samples in 50 persons with type 1 diabetes to evaluate the behavior of different biomarkers (glucose, lactate, beta-hydroxybutyrate), and hormones (cortisol, growth hormone) during and after one morning CardioPulmonary Exercise Test and 2 aerobic (90 minutes at 40-45% of VO2 max) exercise tests under different circumstances (see Protocol).

NCT ID: NCT05428943 Completed - Clinical trials for Diabetes Mellitus, Type 1

OPT101 in Type 1 Diabetes Patients

Start date: September 27, 2022
Phase: Phase 1
Study type: Interventional

Phase 1b designed to assess safety, pharmacokinetics, immunological and clinical effects of multiple ascending doses of OPT101.

NCT ID: NCT05427916 Terminated - Diabetes Clinical Trials

Closed Incision Negative Pressure Wound Therapy vs. Foam as Post Operative Dressing

Start date: July 12, 2022
Phase: N/A
Study type: Interventional

The primary objective is to assess the frequency of a wound healing complication, in a closed incisional wound in a "high risk" surgical incision when treated with Negative Pressure Wound Therapy versus a highly absorbent antimicrobial post - operative absorbent dressing.

NCT ID: NCT05427682 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Pyroglutamate Rongliflozin Capsules in Subjects With Mild and Moderate Liver Damage

Start date: April 19, 2022
Phase: Phase 1
Study type: Interventional

To evaluate the pharmacokinetic characteristics of pyroglutamate rongliflozin capsules in subjects with mild and moderate liver damage and healthy subjects

NCT ID: NCT05427084 Not yet recruiting - Clinical trials for Coronary Artery Disease

Canagliflozin Targeting Vascular Inflammation

CANTORSING
Start date: May 2024
Phase: Phase 2/Phase 3
Study type: Interventional

CANTOR SING is a pilot single center double blinded randomized study. The investigators will compare the effect of canagliflozin (300 mg daily - intervention arm) vs. placebo (control group) on the FDG aortic uptake in patients with stable CAD (over 60 days post-myocardial infarction) after a 6-month period of treatment. The investigators plan to enroll 8 patients in each arm (total sample size: 16 patients). Primary endpoint is the change in FDG aortic uptake between baseline and 6 months in each arm.

NCT ID: NCT05426096 Enrolling by invitation - Diabetes Clinical Trials

Comparison of Intraoperative Best Practice Advisory Reminders to Protocolize Insulin Administration Versus Standard Care in Patients at High Risk of Hyperglycemia

Start date: October 5, 2022
Phase: N/A
Study type: Interventional

This study will assess the implementation of a glucose management clinical decision support tool. The specific objective is to determine if supplementing the existing glucose check reminder with a best practice advisory (BPA), an actionable insulin dosing calculator, providers will be influenced to improve the control of hyperglycemia.

NCT ID: NCT05422807 Completed - Clinical trials for Diabetes Mellitus, Type 2

Behavioral Family Systems Therapy for Teens With Type 2 Diabetes

ADAPT
Start date: April 2011
Phase: N/A
Study type: Interventional

This is a randomized, controlled pilot trial of Behavioral Family Systems Therapy for Teens with Type 2 Diabetes (BFST-DM2), an individual psychological intervention tailored to meet the needs of teens with type 2 diabetes. It is hypothesized that this behavioral family intervention will be feasible to implement with teens with type 2 diabetes and will have positive effects on treatment adherence, health outcomes like weight status and metabolic control, and psychological outcomes.

NCT ID: NCT05421780 Active, not recruiting - Diabetes Clinical Trials

Post-prandial Glycaemic Controlling Effects of BSG in Singapore Adults With Metabolic Syndrome

Start date: June 29, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the glycaemic controlling effects of BSG and bio-transformed BSG-containing biscuits in Singapore adults with MetS. The investigators hypothesized that consumption of BSG and bio-transformed BSG containing biscuit will improve glycaemic control.